Benign Prostatic Hyperplasia
Researchers in the Department of Urology are investigating new methods to treat benign prostatic hyperplasia, including novel medications, surgical techniques, minimally invasive procedures and other approaches to improve patient quality of life and outcomes.
Areas of research in benign prostatic hyperplasia (BPH) include:
- Minimally invasive therapies; interstitial devices such as interstitial laser coagulation and transurethral needle ablation; high-intensity focused ultrasound; and water-induced thermotherapy
- New approaches for Peyronie's disease, including an early trial of inexpensive, safe and well-tolerated oral therapy
- Transurethral microwave heat therapies using standardized treatment protocols and patient selection as opposed to transurethral resection of the prostate and other established BPH treatment modalities to improve safety, efficacy and patient comfort
- Post-implant computerized tomography and transrectal ultrasound (CT/TRUS) image fusion, which could improve the ability to reproduce the effects of various levels of post-implant radiation